| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.38B | 128.17B | 114.28B | 82.42B | 42.33B | 32.65B |
| Gross Profit | 45.17B | 43.44B | 33.13B | 36.32B | 19.31B | 15.00B |
| EBITDA | 11.84B | 11.05B | 2.09B | 9.96B | 11.42B | -259.00M |
| Net Income | 4.67B | 6.04B | 16.31B | 12.63B | 1.12B | -5.34B |
Balance Sheet | ||||||
| Total Assets | 1.27T | 1.27T | 1.21T | 1.12T | 610.63B | 530.46B |
| Cash, Cash Equivalents and Short-Term Investments | 128.82B | 127.89B | 107.95B | 159.39B | 74.65B | 60.59B |
| Total Debt | 75.08B | 69.31B | 61.52B | 39.75B | 26.94B | 67.80B |
| Total Liabilities | 1.10T | 1.09T | 1.05T | 983.58B | 502.69B | 428.00B |
| Stockholders Equity | 151.77B | 157.27B | 151.59B | 117.26B | 95.67B | 91.60B |
Cash Flow | ||||||
| Free Cash Flow | -69.69B | 14.09B | -47.89B | 48.21B | 12.48B | 5.66B |
| Operating Cash Flow | -68.04B | 17.12B | -47.08B | 49.52B | 15.41B | 6.81B |
| Investing Cash Flow | 20.07B | -7.40B | -501.00M | -9.12B | -10.00B | -8.42B |
| Financing Cash Flow | 39.41B | 2.23B | 4.34B | 7.29B | -6.13B | -8.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.27B | 8.24 | ― | 5.80% | 10.85% | 30.77% | |
71 Outperform | ¥79.14B | 7.79 | ― | 2.52% | 13.93% | 54.44% | |
69 Neutral | ¥178.63B | 10.31 | ― | 5.97% | 20.40% | -9.96% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥32.21B | 14.30 | ― | 2.00% | 4.53% | 29.87% | |
63 Neutral | ¥53.04B | 12.37 | 3.37% | 3.27% | -3.40% | 129.82% | |
63 Neutral | ¥36.25B | 149.80 | ― | ― | -33.10% | -49.56% |